Sarat Ventures Y Innovations Biotech Fund to Invest in Early-Stage Companies with a focus in Saudi Arabia and the MENA Region 10-09-2025, 21:00

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed 21-09-2025, 09:15

Iveco Group unveils new Strategic Plan to 2028 and “Unlimited Pathways” for its five Business Units at today’s Capital Markets Day 14-03-2024, 19:00